Jama Author Interviews: Covering Research In Medicine, Science, & Clinical Practice. For Physicians, Researchers, & Clinician

Informações:

Sinopsis

Engaging and topical conversations with authors of research, clinical reviews, and opinion pieces published in JAMA. Subscribe for the latest information, ideas, and innovations in clinical medicine and health policy.

Episodios

  • Making Electronic Health Records More Supportive for Clinicians

    09/08/2022 Duración: 20min

    Electronic health records (EHRs) hold great promise to assist clinicians, but current versions are less user-friendly than ideal. JAMA Associate Editor Tracy Lieu, MD, MPH, spoke with Kevin B. Johnson, MD, MS, University of Pennsylvania, and William W. Stead, MD, Vanderbilt University Medical Center, about how to improve EHRs to protect cognitive attention and optimize their potential to provide cognitive support to health care professionals. Related Content: Making Electronic Health Records Both SAFER and SMARTER

  • Long COVID: The US Federal Response

    03/08/2022 Duración: 16min

    On August 3, 2022, the US Department of Health and Human Services released 2 major reports in response to a presidential memo calling for a whole-of-government response to the SARS-CoV-2 sequelae known as “Long COVID." JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discusses these new reports and the research and support needed to address this pervasive health concern with HHS Assistant Secretary for Health Rachel Levine, MD. Recorded July 29, 2022. Related Content: Addressing the Long-term Effects of COVID-19 Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers Long COVID: The US Federal Response (Video)

  • USPSTF Recommendation: Behavioral Counseling Interventions to Promote Healthy Behaviors for CVD Prevention

    26/07/2022 Duración: 19min

    Interview with Lori Pbert, PhD, USPSTF member and coauthor of Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Senior Editor Kristin L. Walter, MD, MS. Related Content: Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity to Prevent CVD in Adults Without Risk Factors Implications of the New Recommendation on Behavioral Counseling Interventions to Promote Healthy Eating and Physical Activity Improving Behavioral Counseling for P

  • Can Omecamtiv Mecarbil Improve Peak Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)?

    19/07/2022 Duración: 20min

    Exercise limitation is a cardinal manifestation of heart failure with reduced ejection fraction (HFrEF), but it is not consistently improved by any of the current guideline-directed medical therapies. JAMA Deputy Editor Gregory Curfman, MD, discusses whether omecamtiv mecarbil can improve peak exercise capacity in patients with HFrEF with Gregory D. Lewis, MD, from Massachusetts General Hospital, and Mark H. Drazner, MD, MSc, from University of Texas Southwestern Medical Center. Related Content: Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial Omecamtiv Mecarbil as a Therapy for Heart Failure With Low Ejection Fraction

  • Diagnosis, Prevention, and Treatment of Monkeypox

    15/07/2022 Duración: 17min

    JAMA Associate Editor Preeti Malani, MD, MSJ, discusses the transmission, diagnosis, and treatment of monkeypox and the 2022 outbreak with Jeannette Guarner, MD, and Carlos del Rio, MD, both of the Division of Infectious Diseases at Emory University’s School of Medicine. Related Content: Monkeypox in 2022—What Clinicians Need to Know What Is Monkeypox? What to Know About Monkeypox Global Monkeypox Outbreaks Spur Drug Research for the Neglected Disease

  • Progress in Adverse Event Rates in US Hospitalized Patients

    12/07/2022 Duración: 15min

    Patient safety is a national priority, but adverse events during hospitalization are hard to track and whether progress has been made over the past decade is unknown. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, Washington University School of Medicine, discusses recent findings demonstrating decreases in hospital chart-abstracted adverse events and what’s next in patient safety in the wake of COVID-19, with Mark Metersky, MD, University of Connecticut Health Center, and Peter Pronovost, MD, PhD, University Hospitals, Shaker Heights, Ohio. Related Content: Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019 Improvements in Hospital Adverse Event Rates: Achieving Statistically Significant and Clinically Meaningful Results

  • A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief

    05/07/2022 Duración: 22min

    In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. Related Content: The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (video) A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (audio)

  • The Association of Bariatric Surgery With Risk of Cancer in Adults With Obesity

    28/06/2022 Duración: 19min

    Observational data suggest that the risk of certain types of cancer may be increased in individuals with obesity and that this risk may be lower after bariatric surgery. JAMA Deputy Editor Gregory Curfman, MD, explores this in detail with Steven Nissen, MD, an author of a JAMA study on this topic, and Anita Courcoulas, MD, MPH, author of an accompanying editorial. Related Content: Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity Bariatric Surgery and Cancer Risk

  • USPSTF Recommendation: Vitamin and Mineral Supplementation to Prevent CVD and Cancer

    21/06/2022 Duración: 10min

    Interview with John B Wong, MD, USPSTF member and coauthor of Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Deputy Editor Mary M. McDermott, MD. Related Content: Multivitamins and Supplements—Benign Prevention or Potentially Harmful Distraction? Patient Information: Vitamins and Minerals to Prevent Cardiovascular Disease and Cancer

  • Occupational Well-being Among Clinicians

    07/06/2022 Duración: 29min

    Interview with Lisa Rotenstein, MD, MBA, author of A Learning Health System Agenda for Organizational Approaches to Enhancing Occupational Well-being Among Clinicians, and Clyde W. Yancy, MD, author of Resident Physician Wellness Postpandemic: How Does Healing Occur?. Hosted by JAMA Associate Editor Anne Cappola, MD.

  • USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults

    24/05/2022 Duración: 11min

    Interview with Katrina Erika Donahue, MD, MPH, coauthor of Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement, and Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Deputy Editor Mary M. McDermott, MD. Related Content: USPSTF Review: Screening for Glaucoma in Adults USPSTF Review: Screening for Impaired Visual Acuity in Older Adults Patient Information: Screening for Primary Open-Angle Glaucoma Screening for Impaired Visual Acuity in Older Adults Patient Information: Screening for Impaired Visual Acuity in Older Adults Screening for Glaucoma

  • Q&A With White House COVID-19 Response Coordinator Ashish Jha

    18/05/2022 Duración: 23min

    As the White House’s COVID-19 Response Coordinator, Ashish Jha, MD, MPH, plays a critical role in the federal government’s continued response to the pandemic. In this Q&A with JAMA Associate Editor Preeti Malani, MD, Jha details current thinking and federal planning around additional boosters, testing trends, and treatment for COVID-19. Related Content: New White House COVID-19 Leader on What’s Next Q&A With White House COVID-19 Response Coordinator Ashish Jha

  • USPSTF Recommendation: Screening for Chronic Obstructive Pulmonary Disease

    10/05/2022 Duración: 09min

    Interview with Katrina E. Donahue, MD, MPH, USPSTF member and coauthor of Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement. Hosted by JAMA Senior Editor Kristin Walter, MD. Related Content: USPSTF Review: Screening for Chronic Obstructive Pulmonary Disease Screening for Chronic Obstructive Pulmonary Disease: Challenges and Opportunities USPSTF Recommendation: Screening for Chronic Obstructive Pulmonary Disease Patient Information: Screening for Chronic Obstructive Pulmonary Disease

  • Q&A With FDA Commissioner Robert Califf

    04/05/2022 Duración: 23min

    After serving as commissioner of the US Food and Drug Administration (FDA) under President Obama, Robert M. Califf, MD, recently returned to the role, overseeing a critical federal agency that regulates food, drugs, therapeutics, and medical devices in the US. In a wide-ranging discussion with JAMA Deputy Editor Gregory Curfman, MD, Califf discusses COVID-19 vaccine modifications, the FDA’s approach to evaluating evidence, and efforts to combat health misinformation. Recorded April 26, 2022. Related Content:

  • USPSTF Recommendation: Aspirin Use for Cardiovascular Disease

    26/04/2022 Duración: 14min

    Interview with John B. Wong, MD, USPSTF member and coauthor of Aspirin Use for Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Deputy Editor Gregory Curfman, MD. Related Content: Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement Should Patients Take Aspirin for Primary Cardiovascular Prevention? USPSTF Review: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force Patient Information: Use of Aspirin to Prevent Cardiovascular Disease Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease

  • Reducing “COVID-19 Misinformation” While Preserving Free Speech

    19/04/2022 Duración: 24min

    Misinformation about COVID-19 (such as around vaccines, masks, and ineffective drugs) has circulated widely during the pandemic, and much of this misinformation is protected by the Free Speech Clause of the First Amendment. Professor of Surgery and Perioperative Care and Professor of Law William M. Sage, MD, JD, from the University of Texas at Austin, is interviewed in this JAMA podcast. Related Content: Reducing “COVID-19 Misinformation” While Preserving Free Speech

  • Examining the Association of Left Atrial Function and Size With Incident Dementia

    22/03/2022 Duración: 12min

    Electrocardiographic markers of atrial myopathy are associated with dementia, but it is unclear whether 2-dimensional echocardiographic––defined LA function and size are associated with dementia. JAMA Senior Editor Philip Greenland, MD, discusses study findings with Wendy Wang, MPH, and Lin Yee Chen, MD, authors of Association of Echocardiographic Measures of Left Atrial Function and Size With Incident Dementia

  • Leading Medicare: Q&A With Medicare Director Meena Seshamani

    16/03/2022 Duración: 26min

    As the largest public insurance program in the US, Medicare has an outsize influence in how many people in the US access and receive health care. Recently appointed Director of Center for Medicare Meena Seshamani, MD, PhD, joins JAMA Associate Editor Karen Joynt Maddox, MD, for a discussion of equitable, patient-centered approaches to health care delivery, and how her own experiences as a physician have illuminated how she leads the program. Related Content: Center for Medicare Director Envisions Holistic Approach to Health Care Leading Medicare: Q&A With Medicare Director Meena Seshamani Health System Factors Related to Overuse of Health Services in Medicare

  • USPSTF Recommendation: Screening for Eating Disorders in Adolescents and Adults

    15/03/2022 Duración: 12min

    Interview with Lori Pbert, PhD, USPSTF member and coauthor of Screening for Eating Disorders in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement

  • USPSTF Recommendation: Screening for Atrial Fibrillation

    25/01/2022 Duración: 16min

    Interview with Gbenga Ogedegbe, MD, MPH, USPSTF member and coauthor of Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement. Hosted by Gregory Curfman, MD.

página 5 de 41